Age, Tumor Characteristics, and Treatment Regimen as Event Predictors in Ewing: A Children’s Oncology Group   Report

<div>EFS for 1444 patients enrolled in consecutive COG trials. The 5-year EFS for the group was 68.32%  ± 1.3%. EFS = event-free survival; COG = Children’s Oncology Group.</div>

Sarcoma

fig2

Figure 2

Figure 2: Age, Tumor Characteristics, and Treatment Regimen as Event Predictors in Ewing: A Children’s Oncology Group   Report 